EntryPoint Capital’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15,012
Closed -$328K 751
2025
Q4
$328K Sell
15,012
-4,213
-22% -$87.5K 0.13% 323
2025
Q3
$413K Buy
+19,225
New +$431K 0.16% 234
2024
Q4
Sell
-9,582
Closed -$361K 714
2024
Q3
$361K Buy
+9,582
New +$369K 0.21% 170

Other funds holding ATEX

EntryPoint Capital's ATEX Position: Q1 2026 in Review

EntryPoint Capital sold out of Anterix (ATEX) in Q1 2026, closing a stake of 15,012 shares — an estimated $328K sold.

EntryPoint Capital first reported a position in ATEX in Q3 2024 and held it in 3 quarters. The position peaked at $413K in Q3 2025. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • EntryPoint Capital reported no remaining Anterix position as of Q1 2026 after selling out during the quarter.
  • EntryPoint Capital sold 15,012 Anterix shares in Q1 2026, an estimated $328K.
  • EntryPoint Capital first reported a position in Anterix in Q3 2024 and held it in 3 quarters.
  • EntryPoint Capital's Anterix position peaked at $413K in Q3 2025.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on EntryPoint Capital's 13F filing for Q1 2026, filed 14 May 2026.